Correlation Between Kane Biotech and India Globalization

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kane Biotech and India Globalization at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kane Biotech and India Globalization into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kane Biotech and India Globalization Capital, you can compare the effects of market volatilities on Kane Biotech and India Globalization and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kane Biotech with a short position of India Globalization. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kane Biotech and India Globalization.

Diversification Opportunities for Kane Biotech and India Globalization

0.35
  Correlation Coefficient

Weak diversification

The 3 months correlation between Kane and India is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Kane Biotech and India Globalization Capital in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on India Globalization and Kane Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kane Biotech are associated (or correlated) with India Globalization. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of India Globalization has no effect on the direction of Kane Biotech i.e., Kane Biotech and India Globalization go up and down completely randomly.

Pair Corralation between Kane Biotech and India Globalization

Assuming the 90 days horizon Kane Biotech is expected to under-perform the India Globalization. In addition to that, Kane Biotech is 1.79 times more volatile than India Globalization Capital. It trades about -0.08 of its total potential returns per unit of risk. India Globalization Capital is currently generating about 0.02 per unit of volatility. If you would invest  38.00  in India Globalization Capital on September 24, 2024 and sell it today you would earn a total of  0.00  from holding India Globalization Capital or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Kane Biotech  vs.  India Globalization Capital

 Performance 
       Timeline  
Kane Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kane Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's forward indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
India Globalization 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in India Globalization Capital are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating technical and fundamental indicators, India Globalization exhibited solid returns over the last few months and may actually be approaching a breakup point.

Kane Biotech and India Globalization Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kane Biotech and India Globalization

The main advantage of trading using opposite Kane Biotech and India Globalization positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kane Biotech position performs unexpectedly, India Globalization can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in India Globalization will offset losses from the drop in India Globalization's long position.
The idea behind Kane Biotech and India Globalization Capital pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Transaction History
View history of all your transactions and understand their impact on performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope